The Republican party yesterday took a major step towards their long-promised goal of repealing Obamacare – but it’s far from clear if they can agree on what should replace it.
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.